共 50 条
Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4)
被引:25
|作者:
Bookhout, Christine
[1
]
Bouldin, Thomas W.
[1
]
Ellison, David W.
[2
]
机构:
[1] Univ N Carolina, Dept Surg Pathol, Chapel Hill, NC 27599 USA
[2] St Jude Childrens Res Hosp, Dept Neuropathol, 332 N Lauderdale St, Memphis, TN 38105 USA
关键词:
atypical teratoid;
rhabdoid tumor;
BRG1;
INI1;
SMARCA4;
SMARCB1;
CENTRAL-NERVOUS-SYSTEM;
MALIGNANT RHABDOID TUMOR;
SMALL-CELL-CARCINOMA;
PREDISPOSITION SYNDROME;
HYPERCALCEMIC TYPE;
HSNF5/INI1;
MUTATIONS;
GERMLINE;
CLASSIFICATION;
PROGNOSIS;
D O I:
10.1111/neup.12452
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
Atypical teratoid/rhabdoid tumor (AT/RT) is a rare, highly aggressive malignancy of the central nervous system (CNS) usually diagnosed in infancy or childhood, most often characterized by loss of expression of the SMARCB1 gene product integrase interactor 1 (INI1) protein. We report a case of AT/RT in a 3month old boy with retained expression of INI1 by immunohistochemistry. Additional testing demonstrated loss of expression of the SMARCA4 gene product Brahma-related gene 1 (BRG1) protein by immunohistochemistry, confirmed by next generation sequencing showing a nonsense mutation in SMARCA4. This case illustrates that positivity for INI1 does not rule out a diagnosis of AT/RT, and additional testing, including BRG1/SMARCA4 analysis, is warranted in cases where clinical suspicion is high.
引用
下载
收藏
页码:305 / 308
页数:4
相关论文